The federal multidistrict litigation (MDL) over Ozempic and other GLP-1 drugs continues to expand, now encompassing claims related to Saxenda but remaining focused on gastrointestinal injuries like gastroparesis, small bowel obstruction, and gallbladder issues
Sanofi Positioning: Sanofi is a minor player in the GLP-1 market, offering SOLIQUA , a combination therapy that merges insulin glargine with lixisenatide, a GLP-1 receptor agonist
A 2015 New England Journal of Medicine study followed 3,731 participants who were overweight or obese
PMCID: PMC4760683
This makes L-carnitine a valuable supplement for women managing PCOS symptoms
It was a lot of eating food when I wasnt home or asking for extra money, saying I needed lunch money, and going to the vending machine, things of that nature. As an adult, he said, targeted social media ads and the constant availability of food delivery made it easy to binge and hard to stop